April 2010
Volume 51, Issue 13
ARVO Annual Meeting Abstract  |   April 2010
Incidence of Concomitant Cataract and Dry Eye: A Prospective Health Assessment of Cataract Patients’ Ocular Surface
Author Affiliations & Notes
  • W. Trattler
    Director of Cornea, Center For Excellence in Eye Care, Miami, Florida
  • E. Donnenfeld
    Ophthalmic Consultants of Long Island, Rockville Centre, New York
  • P. Majmudar
    Midwest Eye Professionals, Hoffman Estates, Illinois
  • J. Vukich
    Davis Duehr Dean, Madison, Wisconsin
  • D. Goldberg
    Wolstan and Goldberg Eye Associates, Torrence, California
  • G. Berdy
    Ophthalmology Associates, St. Louis, Missouri
  • P. Karpecki
    Koffler Vision Group, Lexington, Kentucky
  • M. Packer
    Fine, Hoffman, & Packer, LLC, Eugene, Oregon
  • C. Reilly
    Wilford Hall Air Force Medical Center, San Antonio, Texas
  • K. Stonecipher
    Southeastern Laser and Refractive Surgery, Greenboro, North Carolina
  • Footnotes
    Commercial Relationships  W. Trattler, AMO, C; Allergan, C; E. Donnenfeld, Advanced Medical Optics, C; Allergan, Inc., C; Alcon Laboratories, Inc., C; Advanced Vision Research, C; Bausch & Lomb, Inc., C; Eyemaginations, Inc, C; Pfizer, C; QLT, C; TLC, C; Wavetec, C; P. Majmudar, None; J. Vukich, STAAR Surgicial Company, C; Alcon Laboratories, Inc., C; Oculus Optikgeraete GmbH, C; AcuFocus, C; Abbott Medical Optics, C; Carl Zeiss Medtec, C; Allergan Inc., C; D. Goldberg, None; G. Berdy, None; P. Karpecki, Alcon, C; Allergan Inc., C; Abbott Medical Optics, C; Bausch & Lomb, C; Ciba, C; Cooper, C; Paragon Vision, C; Johnson & Johnson, C; SynergEyes, C; M. Packer, Johnson & Johnson, C; Vistakon, C; Abbot Medical Optics, Inc., C; Advanced Vision Science, C; Bausch & Lomb Surgical, C; Candeo Clinical/Science Communications, C; Carl Zeiss Inc, C; Gerson Lehman Group, Inc., C; Ista Pharmacuticals, C; iTherapeutix, Inc., C; Leerink Swann & Company, C; Rayner Intraocular Lenses Ltd, C; Sirion Therapeutics, Inc., C; Transcend Medical, Inc., C; TrueVision Systems, Inc., C; Visiogen, Inc., C; Vision Care Inc., C; WaveTec Vision Systems, C; C. Reilly, None; K. Stonecipher, Alcon Laboratories, Inc., C; Allergan Inc., C; Ista Pharmacuticals, C; Inspire, C; Lifeguard, C; Nidek, Inc., C; Oculus Optikgeraete GmbH, C; OASIS Medical, Inc., C; Sirion, C; TLC, C; Vistakon Johnson & Johnson, C.
  • Footnotes
    Support  Unrestricted grant
Investigative Ophthalmology & Visual Science April 2010, Vol.51, 5411. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      W. Trattler, E. Donnenfeld, P. Majmudar, J. Vukich, D. Goldberg, G. Berdy, P. Karpecki, M. Packer, C. Reilly, K. Stonecipher; Incidence of Concomitant Cataract and Dry Eye: A Prospective Health Assessment of Cataract Patients’ Ocular Surface. Invest. Ophthalmol. Vis. Sci. 2010;51(13):5411.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To determine the incidence and severity of dry eye in patients undergoing cataract surgery as determined by grade on the International Task Force (ITF) scale.

Methods: : Prospective, multi-center, observational, pilot study of 200 patients at least 55 years of age that are scheduled to undergo cataract surgery. The primary outcome measure is the incidence of dry eye as evaluated by grade on ITF level and secondary outcome measures include TBUT, OSDI, corneal staining with fluorescein, conjunctival staining with lissamine, and patient questionnaire to evaluate symptoms of dry eye.

Results: : In a preliminary analysis of 49 patients, forty-five percent of patients reported dryness and foreign body sensation. The mean OSDI score was 28.2. The average TBUT was 4.94 seconds, with 64.3% of eyes having a TBUT of 5 seconds or less. 50.5% of eyes had central cornea staining with fluorescein dye. 22.8% of eyes had a Schirmer’s score of 5 or less.

Conclusions: : The prevalence of dry eye in patients scheduled to undergo cataract surgery is higher than generally reported. Increased awareness of dry eye symptoms may result in greater propensity to treat dry eye disease and reduce the incidence and severity of dry eye symptoms induced or worsened by cataract surgery.

Clinical Trial: : www.clinicaltrials.gov NCT01016405

Keywords: cataract • cornea: tears/tear film/dry eye 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.